HRP20050833A2 - Pyrroloimidazole derivatives, their preparation, pharmaceutical composition containing them, and their use as nootropic agents - Google Patents

Pyrroloimidazole derivatives, their preparation, pharmaceutical composition containing them, and their use as nootropic agents Download PDF

Info

Publication number
HRP20050833A2
HRP20050833A2 HR20050833A HRP20050833A HRP20050833A2 HR P20050833 A2 HRP20050833 A2 HR P20050833A2 HR 20050833 A HR20050833 A HR 20050833A HR P20050833 A HRP20050833 A HR P20050833A HR P20050833 A2 HRP20050833 A2 HR P20050833A2
Authority
HR
Croatia
Prior art keywords
pyrrolo
imidazole
dione
tetrahydro
phenyl
Prior art date
Application number
HR20050833A
Other languages
English (en)
Croatian (hr)
Inventor
Farina Carlo
Gagliardi Stefania
Parini Carlo
Martinelli Marisa
Ghelardini Carla
Original Assignee
Nikem Research S.R.L.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nikem Research S.R.L. filed Critical Nikem Research S.R.L.
Publication of HRP20050833A2 publication Critical patent/HRP20050833A2/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HR20050833A 2003-03-24 2004-03-22 Pyrroloimidazole derivatives, their preparation, pharmaceutical composition containing them, and their use as nootropic agents HRP20050833A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000573A ITMI20030573A1 (it) 2003-03-24 2003-03-24 Composti ad azione nootropica, loro preparazione,
PCT/EP2004/050339 WO2004085438A2 (en) 2003-03-24 2004-03-22 Pyrroloimidazole derivatives, their preparation, pharmaceutical composition containing them, and their use as nootropic agents

Publications (1)

Publication Number Publication Date
HRP20050833A2 true HRP20050833A2 (en) 2006-02-28

Family

ID=33042696

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20050833A HRP20050833A2 (en) 2003-03-24 2004-03-22 Pyrroloimidazole derivatives, their preparation, pharmaceutical composition containing them, and their use as nootropic agents

Country Status (23)

Country Link
US (3) US7544705B2 (da)
EP (1) EP1608655B8 (da)
JP (1) JP4920408B2 (da)
CN (1) CN100522963C (da)
AT (1) ATE401327T1 (da)
AU (1) AU2004224087B2 (da)
BR (1) BRPI0408601A (da)
CA (1) CA2520008C (da)
CY (1) CY1108401T1 (da)
DE (1) DE602004015089D1 (da)
DK (1) DK1608655T3 (da)
EA (1) EA009558B1 (da)
ES (1) ES2309534T3 (da)
HR (1) HRP20050833A2 (da)
IT (1) ITMI20030573A1 (da)
NO (1) NO20054898L (da)
NZ (1) NZ543154A (da)
PL (2) PL1608655T3 (da)
PT (1) PT1608655E (da)
RS (1) RS20050725A (da)
SI (1) SI1608655T1 (da)
WO (1) WO2004085438A2 (da)
ZA (1) ZA200508578B (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20030573A1 (it) * 2003-03-24 2004-09-25 Nikem Research Srl Composti ad azione nootropica, loro preparazione,
EP1925304A1 (en) * 2006-11-15 2008-05-28 Nikem Research S.R.L. Pyrrolo[1,2-a]imidazoledione effective in the treatment of peripheral neurotoxicity induced by chemotherapeutic agents
AU2012201853B2 (en) * 2007-04-16 2013-06-27 Neurotune Ag Use of dimiracetam in the treatment of chronic pain
ITMI20070770A1 (it) * 2007-04-16 2008-10-17 Brane Discovery S R L Impiego di dimiracetam nel trattamento del dolore cronico
EP3260118B1 (en) 2008-10-16 2021-03-24 The Johns Hopkins University Methods and compositions for improving cognitive function
US9125898B2 (en) 2008-11-14 2015-09-08 Neurotune Ag Acetam derivatives for pain relief
US20110212928A1 (en) * 2010-02-09 2011-09-01 The Johns Hopkins University Methods and compositions for improving cognitive function
US8476453B2 (en) * 2010-07-26 2013-07-02 Neurotune Ag Process for the preparation of dimiracetam
WO2014078568A1 (en) 2012-11-14 2014-05-22 The Johns Hopkins University Methods and compositions for treating schizophrenia
EP2968220B1 (en) 2013-03-15 2021-05-05 Agenebio, Inc. Methods and compositions for improving cognitive function
WO2014144663A1 (en) 2013-03-15 2014-09-18 The Johns Hopkins University Methods and compositions for improving cognitive function
NZ738682A (en) 2015-05-22 2022-01-28 Agenebio Inc Extended release pharmaceutical compositions of levetiracetam
JOP20190251A1 (ar) 2017-05-31 2019-10-21 Metys Pharmaceuticals AG تركيبات تآزرية تشتمل على (r)-ديميراسيتام (1) و(s)-ديميراسيتام (2) بنسبة غير راسيمية
JP2022510362A (ja) 2018-12-04 2022-01-26 メティス ファーマシューティカルズ アクチェンゲゼルシャフト Ｒ－２－（置換スルホニル）－ヘキサヒドロ－ピロロ［１，２－ａ］ピラジン－６（２Ｈ）－オンとＳ－２－（置換スルホニル）－ヘキサヒドロ－ピロロ［１，２－ａ］ピラジン－６（２Ｈ）－オンを非ラセミ比で含む相乗的組成物
HUE062575T2 (hu) 2018-12-04 2023-11-28 Metys Pharmaceuticals AG (R)-2-(2-oxopirrolidin-1-il)-butánamidot és (S)-2-(2-oxopirrolidin-1-il)-butánamidot nem-racém arányban tartalmazó szinergetikus kompozíciók

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4582838A (en) * 1984-08-24 1986-04-15 Warner-Lambert Company Derivatives of dihydro-1H-pyrrolo[1,2-c]imidazol-3,5-dione as cognition activators
IT1233860B (it) * 1988-02-08 1992-04-21 Isf Spa Derivati del peridroazacicloalca (1,2-a) imidazolo ad attivita' nootropa
US5200406A (en) * 1988-02-08 1993-04-06 I.S.F. Societa Per Azioni Pharmaceutically useful 2,5-dioxo-1H-octahydroimidazo[1,2-A]azepines
JP3400466B2 (ja) * 1991-10-28 2003-04-28 日本水産株式会社 高純度エイコサペンタエン酸またはそのエステルの製造方法
GB9123641D0 (en) * 1991-11-07 1992-01-02 Isf Spa Process
ITMI20030573A1 (it) * 2003-03-24 2004-09-25 Nikem Research Srl Composti ad azione nootropica, loro preparazione,
EP1925304A1 (en) * 2006-11-15 2008-05-28 Nikem Research S.R.L. Pyrrolo[1,2-a]imidazoledione effective in the treatment of peripheral neurotoxicity induced by chemotherapeutic agents

Also Published As

Publication number Publication date
ZA200508578B (en) 2007-04-25
CA2520008A1 (en) 2004-10-07
ITMI20030573A1 (it) 2004-09-25
US7732473B2 (en) 2010-06-08
EP1608655B8 (en) 2008-10-15
WO2004085438A3 (en) 2004-11-25
US20070027137A1 (en) 2007-02-01
EA009558B1 (ru) 2008-02-28
PL1608655T3 (pl) 2009-03-31
CN1756757A (zh) 2006-04-05
NO20054898L (no) 2005-10-24
US7544705B2 (en) 2009-06-09
DE602004015089D1 (de) 2008-08-28
CN100522963C (zh) 2009-08-05
US20090163565A1 (en) 2009-06-25
ES2309534T3 (es) 2008-12-16
CY1108401T1 (el) 2014-02-12
AU2004224087B2 (en) 2010-04-01
NZ543154A (en) 2008-03-28
AU2004224087A1 (en) 2004-10-07
EP1608655A2 (en) 2005-12-28
JP4920408B2 (ja) 2012-04-18
ATE401327T1 (de) 2008-08-15
EP1608655B1 (en) 2008-07-16
PL378939A1 (pl) 2006-06-12
CA2520008C (en) 2011-08-23
PT1608655E (pt) 2008-10-07
RS20050725A (sr) 2007-11-15
WO2004085438A2 (en) 2004-10-07
JP2006523198A (ja) 2006-10-12
EA200501501A1 (ru) 2006-04-28
BRPI0408601A (pt) 2006-03-07
SI1608655T1 (sl) 2008-12-31
US20100173945A1 (en) 2010-07-08
DK1608655T3 (da) 2008-11-03
HK1083837A1 (en) 2006-07-14

Similar Documents

Publication Publication Date Title
US7732473B2 (en) Compounds with nootropic action, their preparation, pharmaceutical compositions containing them, and use thereof
US6583147B1 (en) Pyrazolopyrimidinone derivatives for the treatment of impotence
TWI801388B (zh) 二氮雜雙環經取代之咪唑并嘧啶類及其用途
WO1998029397A1 (en) Fused pyrimidine compounds and medicinal use thereof
EP0623621A1 (en) Oxazabicyclo derivatives and their use as 5-HT4 receptor agonists
JP2006516653A (ja) キナーゼ阻害剤ピロロトリアジンの製造方法
AU616240B2 (en) 2,5-dioxohexahydro-1H-pyrrolo(1,2-a)imidazole pyridine and azepine derivatives
JP2006525302A (ja) ニコチン性アセチルコリン受容体の正のモジュレーター
EP0934319A1 (fr) DERIVES DE 1H-PYRIDO[3,4-b]INDOLE-4-CARBOXAMIDE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
JPH11193289A (ja) ピロールスルホンアミド誘導体
WO2008032764A1 (en) Fused heterocyclic derivative
HU186028B (en) Process for preparing pyrrolo-benzoidiazepines
FR2601951A1 (fr) Nouvelles tetrahydrocarbazolones, composition pharmaceutique les contenant et leur procede de preparation
MXPA05009903A (en) Pyrroloimidazole derivatives, their preparation, pharmaceutical composition containing them, and their use as nootropic agents
JP2941702B2 (ja) ５‐ｈｔ３レセプターにおいて５‐ｈｔの作用に拮抗するラクタム誘導体を含む医薬組成物
HK1083837B (en) Pyrroloimidazole derivatives, their preparation, pharmaceutical compositions containing them, and their use as nootropic agents
WO2004080965A1 (ja) ニューロペプチドff受容体拮抗剤
KR20070035046A (ko) (1ｓ,5ｓ)-3-(5,6-디클로로-3-피리디닐)-3,6-디아자비사이클로[3.2.0]헵탄
JP2000344775A (ja) 新規化合物及び該化合物を含有する医薬組成物

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
PPPP Transfer of rights

Owner name: BRANE DISCOVERY S.R.L., IN IN LIQUIDAZIONE, IT

ODRP Renewal fee for the maintenance of a patent

Payment date: 20100320

Year of fee payment: 7

OBST Application withdrawn